Cargando…
Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study
Information on medication utilization among pregnant and postpartum women during the pandemic is lacking. We described the prevalence and patterns of self-reported medication use among pregnant and postpartum women during the third wave of the pandemic (June–August 2021). An online questionnaire was...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100043/ https://www.ncbi.nlm.nih.gov/pubmed/35564733 http://dx.doi.org/10.3390/ijerph19095335 |
_version_ | 1784706756341923840 |
---|---|
author | Gerbier, Eva Favre, Guillaume Tauqeer, Fatima Winterfeld, Ursula Stojanov, Milos Oliver, Alison Passier, Anneke Nordeng, Hedvig Pomar, Léo Baud, David Panchaud, Alice Meyer-Massetti, Carla Ceulemans, Michael |
author_facet | Gerbier, Eva Favre, Guillaume Tauqeer, Fatima Winterfeld, Ursula Stojanov, Milos Oliver, Alison Passier, Anneke Nordeng, Hedvig Pomar, Léo Baud, David Panchaud, Alice Meyer-Massetti, Carla Ceulemans, Michael |
author_sort | Gerbier, Eva |
collection | PubMed |
description | Information on medication utilization among pregnant and postpartum women during the pandemic is lacking. We described the prevalence and patterns of self-reported medication use among pregnant and postpartum women during the third wave of the pandemic (June–August 2021). An online questionnaire was distributed in five European countries between June–August 2021. Pregnant women or women who had delivered in the three preceding months, and ≥18 years old, could participate. The prevalence of overall medication use, self-medication, and changes in chronic medication use were determined. A total of 2158 women out of 5210 participants (41.4%) used at least one medication. Analgesics (paracetamol), systemic antihistamines (cetirizine), and drugs for gastric disorders (omeprazole) were the three most used classes. Anti-infectives were less prevalent than during pre-pandemic times. Antidepressants and anxiety related medication use remained similar, despite a higher prevalence of these symptoms. Self-medication was reported in 19.4% of women, and 4.1% of chronic medication users reported that they changed a chronic medication on personal initiative due to the pandemic. In conclusion, medication use patterns in our cohort were mostly similar to those of the first COVID-19 wave and the pre-pandemic period. More studies are needed to explore factors associated with self-medication and changes in chronic medication use due to the pandemic in this perinatal population. |
format | Online Article Text |
id | pubmed-9100043 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91000432022-05-14 Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study Gerbier, Eva Favre, Guillaume Tauqeer, Fatima Winterfeld, Ursula Stojanov, Milos Oliver, Alison Passier, Anneke Nordeng, Hedvig Pomar, Léo Baud, David Panchaud, Alice Meyer-Massetti, Carla Ceulemans, Michael Int J Environ Res Public Health Article Information on medication utilization among pregnant and postpartum women during the pandemic is lacking. We described the prevalence and patterns of self-reported medication use among pregnant and postpartum women during the third wave of the pandemic (June–August 2021). An online questionnaire was distributed in five European countries between June–August 2021. Pregnant women or women who had delivered in the three preceding months, and ≥18 years old, could participate. The prevalence of overall medication use, self-medication, and changes in chronic medication use were determined. A total of 2158 women out of 5210 participants (41.4%) used at least one medication. Analgesics (paracetamol), systemic antihistamines (cetirizine), and drugs for gastric disorders (omeprazole) were the three most used classes. Anti-infectives were less prevalent than during pre-pandemic times. Antidepressants and anxiety related medication use remained similar, despite a higher prevalence of these symptoms. Self-medication was reported in 19.4% of women, and 4.1% of chronic medication users reported that they changed a chronic medication on personal initiative due to the pandemic. In conclusion, medication use patterns in our cohort were mostly similar to those of the first COVID-19 wave and the pre-pandemic period. More studies are needed to explore factors associated with self-medication and changes in chronic medication use due to the pandemic in this perinatal population. MDPI 2022-04-27 /pmc/articles/PMC9100043/ /pubmed/35564733 http://dx.doi.org/10.3390/ijerph19095335 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gerbier, Eva Favre, Guillaume Tauqeer, Fatima Winterfeld, Ursula Stojanov, Milos Oliver, Alison Passier, Anneke Nordeng, Hedvig Pomar, Léo Baud, David Panchaud, Alice Meyer-Massetti, Carla Ceulemans, Michael Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study |
title | Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study |
title_full | Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study |
title_fullStr | Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study |
title_full_unstemmed | Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study |
title_short | Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study |
title_sort | self-reported medication use among pregnant and postpartum women during the third wave of the covid-19 pandemic: a european multinational cross-sectional study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100043/ https://www.ncbi.nlm.nih.gov/pubmed/35564733 http://dx.doi.org/10.3390/ijerph19095335 |
work_keys_str_mv | AT gerbiereva selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy AT favreguillaume selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy AT tauqeerfatima selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy AT winterfeldursula selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy AT stojanovmilos selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy AT oliveralison selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy AT passieranneke selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy AT nordenghedvig selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy AT pomarleo selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy AT bauddavid selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy AT panchaudalice selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy AT meyermassetticarla selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy AT ceulemansmichael selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy |